Amiodarone (Amiodarone)



Indications and Reactions:

Role Indications Reactions
Primary
Atrial Fibrillation 66.7%
Drug Use For Unknown Indication 11.1%
Hypertension 11.1%
Thrombosis Prophylaxis 11.1%
Optic Atrophy 12.5%
Pneumonitis 12.5%
Spider Naevus 12.5%
Staphylococcal Infection 12.5%
Toxicity To Various Agents 12.5%
Tremor 12.5%
Vasculitis 12.5%
Ventricular Hypertrophy 12.5%
Secondary
Product Used For Unknown Indication 25.4%
Myocardial Ischaemia 16.9%
Arrhythmia 9.9%
Drug Use For Unknown Indication 9.9%
Supraventricular Tachycardia 7.0%
Atrial Fibrillation 5.6%
Multiple Myeloma 4.2%
Atrial Flutter 2.8%
Urinary Tract Infection 2.8%
Antibiotic Prophylaxis 1.4%
Cardioversion 1.4%
Depression 1.4%
Endoscopy 1.4%
Epilepsy 1.4%
Gout 1.4%
Grand Mal Convulsion 1.4%
Heart Rate Irregular 1.4%
Hypertension 1.4%
Hypothyroidism 1.4%
Initial Insomnia 1.4%
Torsade De Pointes 12.5%
Renal Failure Acute 8.3%
White Blood Cell Count Decreased 8.3%
Atrial Fibrillation 4.2%
Gastrointestinal Haemorrhage 4.2%
Hallucination 4.2%
International Normalised Ratio Increased 4.2%
Multiple Drug Overdose 4.2%
Presyncope 4.2%
Rash Pruritic 4.2%
Respiratory Failure 4.2%
Sexual Dysfunction 4.2%
Sinus Bradycardia 4.2%
Skin Oedema 4.2%
Syncope 4.2%
Tachyarrhythmia 4.2%
Therapy Non-responder 4.2%
Transaminases Increased 4.2%
Transient Ischaemic Attack 4.2%
Tricuspid Valve Incompetence 4.2%
Concomitant
Drug Use For Unknown Indication 17.0%
Acute Myeloid Leukaemia 9.8%
Multiple Myeloma 9.8%
Plasma Cell Myeloma 7.1%
Non-small Cell Lung Cancer 6.3%
Product Used For Unknown Indication 5.4%
Prophylaxis 5.4%
Septic Shock 4.5%
Atrial Fibrillation 3.6%
Gait Disturbance 3.6%
Stem Cell Transplant 3.6%
Benign Prostatic Hyperplasia 2.7%
Blood Cholesterol Increased 2.7%
Cardiac Failure 2.7%
Chronic Lymphocytic Leukaemia 2.7%
Chronic Myeloid Leukaemia 2.7%
Colitis 2.7%
Hypertension 2.7%
Metastatic Renal Cell Carcinoma 2.7%
Pulmonary Arterial Hypertension 2.7%
Vomiting 12.5%
Thrombocytopenia 8.9%
Renal Failure Acute 7.1%
Pain 5.4%
Pneumonia 5.4%
Septic Shock 5.4%
Somnolence 5.4%
Ventricular Fibrillation 5.4%
Ventricular Tachycardia 5.4%
Atrial Fibrillation 3.6%
Cardiac Arrest 3.6%
Haemoglobin Decreased 3.6%
Multiple Sclerosis Relapse 3.6%
Osteoarthritis 3.6%
Post Procedural Complication 3.6%
Rash 3.6%
Renal Failure Chronic 3.6%
Right Ventricular Failure 3.6%
Splenomegaly 3.6%
Sudden Death 3.6%